A mixed approach for proving non-inferiority in clinical trials with binary endpoints


Autoria(s): Rousson Valentin; Seifert Burkhardt
Data(s)

2008

Resumo

When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints.

Identificador

https://serval.unil.ch/?id=serval:BIB_57153ABBA5E3

isbn:1521-4036[electronic]

pmid:18311852

doi:10.1002/bimj.200710410

isiid:000255262700003

Idioma(s)

en

Fonte

Biometrical journal, vol. 50, no. 2, pp. 190-204

Palavras-Chave #Anti-Bacterial Agents/therapeutic use; Clindamycin/therapeutic use; Data Interpretation, Statistical; Endpoint Determination; Female; Humans; Odds Ratio; Randomized Controlled Trials as Topic/methods; Sample Size; Therapeutic Equivalency; Vaginosis, Bacterial/drug therapy
Tipo

info:eu-repo/semantics/article

article